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In vitro evaluation of the CeVOX continuous central venous
oxygenation monitoring system
Abstract
We investigated the in vitro performance of the CeVOX system for continuous monitoring of central
venous oxygen saturation by spectrophotometry (Pulsion Medical Systems, Munich, Germany). Oxygen
inflow into the system was varied, and oxygen saturation values measured by CeVOX were
documented. Blood samples were simultaneously taken to assess oxygen saturation by co-oximetry, and
values were compared by Bland-Altman analysis. Sixty-six data pairs were obtained at CeVOX and
co-oximetry values of 16-99% and 5.5-100%, respectively. Overall, CeVOX values only slightly
overestimated co-oximetry values (mean bias +2.4%), but limits of agreement (2 SD of bias) were wide
(-11.8 to +16.6%). Saturation measured by CeVOX underestimated that measured by co-oximetry at
higher oxygen concentrations and overestimated it at lower oxygen concentrations. There was a nearly
linear correlation of the mean bias, suggesting a systematic error. We conclude that the current version
of the CeVOX system does not reliably reflect oxygen saturation.
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Summary  
 
We investigated the in vitro performance of the CeVOX system for continuous monitoring of 
central venous oxygen saturation by spectrophotometry. Oxygen inflow into the system was 
varied, and oxygen saturation values measured by CeVOX (ScevoxO2) were documented. 
Blood samples were simultaneously taken to assess oxygen saturation by co-oximetry (SO2), 
and values were compared by Bland-Altman analysis. Sixty-six data pairs were obtained at 
ScevoxO2 and SO2 values ranging between 16–99% and 5.5–100%, respectively. Overall, 
ScevoxO2 only slightly overestimated SO2 (mean bias +2.4%), but limits of agreement (± 2 SD 
of bias) were high (–11.8 / +16.6%). ScevoxO2 underestimated SO2 at higher oxygen 
concentrations and overestimated it at lower oxygen concentrations. There was a nearly linear 
correlation of the mean bias of ScevoxO2 and SO2, suggesting a systematic error. We conclude 
that the current version of the CeVOX system does not reliably reflect SO2 values. 
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 Monitoring of central venous oxygen saturation (ScvO2) is important for guiding 
haemodynamic management in children and adults during major elective surgery [1-4]. It is 
also one of the core targets for early goal-directed therapy in the treatment of septic shock in 
adults [5-8]. Standard means to monitor ScvO2 consist of repeated blood drawing from a 
central venous catheter placed in the superior vena cava and analysis of the blood using co-
oximetry [9]. 
 
However, this approach is intermittent, increases workload and costs, and results in 
contamination of stopcocks and iatrogenic blood loss. Therefore, reliable techniques for 
continuous monitoring of ScvO2 would be desirable. 
 
One such technique is spectrophotometry using near-infrared light [9]. The recently 
introduced CeVOX system (Pulsion Medical Systems, Munich, Germany) consists of a 
disposable spectrophotometric probe that can be inserted into the distal lumen of a central 
venous catheter placed with its tip in the superior vena cava. Tissue chromophores, such as 
haemoglobin, absorb near-infrared light depending on their oxygenation state. Changes in 
chromophore concentrations and oxygenation states, revealed by comparing emitted and 
detected near-infrared light, can therefore be quantified using the modified Lambert-Beer law 
[10-12]. Data are available about the reliability of the CeVOX system [10, 11], but the aim of 
this study was to validate performance of the CeVOX system in an in vitro model. 
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Methods 
 
For the purpose of monitoring ScevoxO2, light of three wavelengths (660, 805 and 880 nm) is 
transmitted through a fiberoptic probe inserted into the distal lumen of a central venous 
catheter placed in the superior vena cava. The tip of the fiberoptic probe must protrude past 
the distal end of the catheter by 2-3 cm. It is connected to the optical module of the CeVOX 
system, and light reflected from the haemoglobin in the red blood cells is transmitted back by 
a second fiberoptic line. The sensor in the optical module analyses the reflected light and 
determines light extinction. This information is transferred to the CeVOX system, and 
ScevoxO2 is calculated and displayed on the screen (Fig 1). Before starting continuous 
measurements, a calibrating maneouver using a blood sample analysed by co-oximetry is 
required.  
 
Experimental set-up 
An 8.5F four-lumen central venous catheter with a length of 20 cm and a distal lumen of 
≥0.038 in (Pulsion Medical Systems) was inserted into a black test chamber with a volume of 
100 cm3. A CeVOX 2F fiberoptic probe (PV2022-35, Pulsion Medical Systems) was 
introduced into the distal lumen of the central venous catheter, secured by the integrated luer 
lock system, and connected to the optical module of the CeVOX device (PC3000, Pulsion 
Medical Systems). The test chamber was connected to a paediatric cardiopulmonary bypass 
circuit consisting of a roller pump and a thermoregulating device (Paediatric Pump S3, 
Stöckert Instruments, Munich, Germany), a Safe Mini oxygenator (Polystan/Maquet-CP, 
Hirlingen, Germany), a Safe Micro Reservoir (Polystan/Maquet-CP) and a real-time blood 
gas analyser unit (CDI 500, Terumo, Eschborn, Germany) to monitor PCO2. Pressurized O2, 
N2 and CO2 were connected to a fresh gas mixer (full automatic gas blender, Stöckert 
Instruments) (Fig 1) to provide air mixtures with various concentrations of oxygen at 
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physiological PCO2. The whole system was filled with 300 ml of human blood provided by 
one of the investigators. Anticoagulation was performed by adding 10,000 IE heparin sodium 
(Hoffman la Roche AG, Grenzach-Wyhlen, Germany). The flow rate provided by the pump 
was kept constant at 1000 ml.min-1 throughout the experiments, and blood pressure in the test 
chamber was held at 15 cm H2O. Blood was warmed to 37°C, and alpha-stat blood PCO2 was 
held within physiological range (5-7 kPa), as continuously monitored by the real-time blood 
gas analyser unit of the extracorporeal circuit and confirmed by blood gas analysis. Blood 
samples were analysed using multi-wavelength haemoximetry (ABL 626/620, Radiometer 
Medical A/S, Akandevey 21, DK-2700 Bronshoj, Denmark). 
 
After steady-state values for ScevoxO2 at 70% were reached, the CeVOX system was calibrated 
according to the reference manual of the manufacturer. The circulating blood was then 
gradually desaturated by changing the fresh gas mixture of the membrane oxygenator from 
oxygen to nitrogen and vice versa. With each change of the oxygen saturation level and after a 
steady-state condition of ScevoxO2 was obtained, ScevoxO2 values were recorded and blood 
samples were taken simultaneously from the distal lumen of the central venous catheter for 
analysis of pH, partial oxygen tension, PCO2, sodium bicarbonate (NaHCO3), base excess, 
SO2, and haemoglobin concentration (Hb). 
 
Statistics 
Data are expressed as mean (±SD) and range as appropriate. Agreement between ScevoxO2 and 
SO2 measured by co-oximetry was assessed by Bland-Altman analysis [13]. Linear regression 
analysis was performed to compare ScevoxO2 and SO2 and the difference values of ScevoxO2 and 
SO2 with SO2. To test the influence of pH, PCO2, NaHCO3, base excess, Hb, and temperature 
on the mean bias of ScevoxO2 and SO2, a multiregression analysis was performed. StatView 
5.02 and SPSS 13 software were used for statistical analysis.
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Results 
 
Three series of measurements were undertaken on three occasions, using identical 
experimental set-ups and, for each set-up, a new fiberoptic probe. A total of 66 ScevoxO2 
readings and simultaneous measurements of SO2 were obtained and analysed. Metabolic 
parameters are listed in Table 1. ScevoxO2 and SO2 ranged between 16–99% and 5.5–100%, 
respectively (Fig 2). Simple regression analysis demonstrated a high linear correlation 
between ScevoxO2 and SO2 (r2=0.97, p<0.0001) (Fig 2). However, the Bland-Altman analysis 
revealed poor agreement between ScevoxO2 and SO2. Although the mean bias was low 
(+2.4%), the limits of agreement (± 2 SD of bias) amounted to –11.8 / +16.6% (Fig 3). 
ScevoxO2 underestimated SO2 at higher values and overestimated it at lower values. A nearly 
linear correlation between the mean bias of ScevoxO2–SO2 and SO2 was found, which is 
expressed by the equation (ScevoxO2–SO2) = 14 – 0.2*SO2(%) (R2 = 0.65, p>0.0001) (Fig 3b). 
Mean bias and limits of agreement of ScevoxO2 and SO2 were similar when data pairs were 
compared between the three fiberoptic probes (data not shown). Mean bias of ScevoxO2 and 
SO2 was influenced by Hb (p = 0.0143) but not by pH, PCO2, NaHCO3  base excess or 
temperature. The subgroup analysis of data pairs in the range 10–49% SO2 and 50–100% SO2 
resulted in a mean bias (limits of agreement) of +9.4% (+1.2 / +17.6%) and –2.1% (–10.9 / 
+6.1%), respectively. 
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Discussion 
 
We investigated the performance of the CeVOX system for continuous monitoring of central 
venous oxygen saturation in an in vitro setting. The main findings were that (1) the agreement 
between ScevoxO2 and SO2, measured by co-oximetry, was poor, especially at low and high 
SO2 values; (2) the CeVOX system considerably overestimated low SO2 values and 
underestimated high SO2 values; and (3) no better agreement was found in the clinically 
relevant range of oxygen saturation.  
 
The technical prerequisites for continuous measurements of oxygen saturation in the blood 
using spectrophotometry have been available for more than 40 years [14]. Multiple clinical 
and experimental investigations have compared oxygen saturation values derived from 
fiberoptic catheters with those obtained by co-oximetry, but the results are inconsistent (Table 
2). Some authors suggested that fiberoptic devices based on three (instead of two) reference 
light wavelengths might increase accuracy [15-18], but this conclusion was based on linear 
correlation coefficients. A high linear regression coefficient, however, is meaningless and can 
be misleading in the context of methods comparison, because correlation does not necessarily 
mean agreement. Other investigators, using Bland-Altman analyses for methods comparison, 
found no difference whether two or three reference light wavelengths were used [19-23].  
 
The CeVOX system, investigated here, is based on three reference light wavelengths and 
characterised by one transmitting and one detecting fiberoptic filament. Advantages of the 
CeVOX system are that it is easy to handle and does not necessitate additional invasive 
venous access because the disposable 2F fiberoptic catheter can be inserted into a standard 
central venous line. Various lengths (30–48 cm) of the fiberoptic catheter facilitate its use in 
connection with a variety of central venous catheters in adults. In infants, however, as 
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recently reported by Müller and colleagues [24], insertion of a separate 16-gauge single-
lumen catheter into a femoral vein is required to enable the use of the 2F fiberoptic probe.  
 
The high linear correlation coefficient between ScevoxO2 and SO2, as measured by co-oximetry 
in the current study, confirms the findings of previous investigators who compared fiberoptic 
measurements of SO2 with SO2 assessed by co-oximetry [15, 23, 25]. Using Bland-Altman 
analysis as the appropriate statistical approach [13], the agreement between ScevoxO2 and SO2, 
measured by co-oximetry in our study, was poor. 
 
Most recently, Huber and colleagues [11] compared SO2 values obtained with a 2F CeVOX 
fiberoptic probe and a 4F Edward oximetry catheter against values measured by co-oximetry 
in an in vitro setting similar to that used in the present study. They reported an excellent 
correlation between fiberoptic measurements and SO2 values determined by co-oximetry for 
both the CeVOX and Edward oximetry fiberoptic probes (r2 = 0.98 and 0.99, respectively). 
However, the Bland-Altman plots for both probes revealed high limits of agreement (–11.2 / 
+10.85 and –7.7 / +9.6, respectively) and demonstrated overestimation at low SO2 and 
underestimation at high SO2. Fiberoptic SO2 values were most accurate near the calibration 
point of 70%. These authors concluded that fiberoptic oximetry and co-oximetry gave nearly 
identical results over a wide range of oxygen saturations, but they recommended repeated 
recalibration to reduce the occasionally observed drift of fiberoptic oximetry values. In the 
current investigation similar results were found, with limits of agreement even higher than 
those reported by Huber and colleagues [11]. Contrary to that study, poor agreement between 
ScevoxO2 and SO2 determined by co-oximetry was also found near the calibration point.  
 
Mean bias of ScevoxO2 and SO2 assessed by co-oximetry in our in vitro study showed a slope, 
suggesting linear dependency on SO2 measured by co-oximetry. Analyzing the two subgroups 
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of data pairs with co-oximetric SO2 ranging from 50–100% and 0–49%, respectively, the 
slope of the mean bias of ScevoxO2 and co-oximetric SO2 was highest in the range 0–49%. The 
subgroup analyses confirmed the overestimation of SO2 in the low range of co-oximetric SO2 
values by ScevoxO2 and the underestimation of SO2 in the high range of ScevoxO2 and co-
oximetric SO2. In both subgroups, however, no difference was found with regard to the limits 
of agreement between ScevoxO2 and SO2 assessed by co-oximetry. The nearly linear 
dependency of the mean bias of ScevoxO2 and SO2 values obtained by co-oximetry on co-
oximetric SO2 values was confirmed when the data obtained by the three different fiberoptic 
probes were analysed separately, possibly suggesting a systematic error in the CeVOX 
algorithm. 
  
One possible reason for the suggested systematic error may be the calibration factor (CAL-
Value) of the CeVOX system, recommended by the manufacturer. Postprocessing the 
measured data by stepwise reduction of the recommended CAL-Value by 7, 16 and 23% led 
to a disappearance of the slope of the mean bias. However, mean bias changed from nearly 0 
to –5.8% without any impact on the limits of agreement.  
Another cause and possible limitation of this study may be the impact of metabolic changes 
oxygen saturation measured by spectrophotometry. In particular, increasing values of carbon 
dioxide tension cannot be manipulated in our experimental setting. Haney and colleagues [28] 
reported in dogs a significant overestimation of spectrophotometrically measured mixed 
venous oxygen saturation as carboxyhaemoglobin increases. Because the CeVOX system 
does not detect the presence of carboxyhaemoglobin we cannot exclude its increase. Carbon 
dioxide tensions in our experimental setting were found to lie between the upper physiologic 
and the hypercapnic range, which may explain in part the overestimation of low oxygen 
saturation values, but not the observed underestimation in the high range of oxygen 
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saturations. Contrary to this in vitro study, the influence of metabolic parameters are 
preventable in an in vivo setting by preserving normocapnia and a balanced metabolic state. 
 
Reliability of continuous central venous oxygen saturation readings is of particular 
importance in the lower range (<60% ScvO2), where therapeutic interventions become 
necessary. During and after palliative congenital cardiac surgery in neonates and small infants 
with cyanotic heart diseases, ScvO2 may range from 35 to 55%. In this setting the CeVOX 
device has serious limitations. 
 
In conclusion, our in vitro evaluation of the CeVOX system revealed poor agreement between 
fiberoptic measurements and saturation values determined by co-oximetry. Whether technical 
advancements and adaptations of the algorithm might improve performance of the CeVOX 
system remains to be seen. 
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Table 1. Metabolic parameters. Values are expressed as mean (SD [range]).  
 
Parameter        
Temp. (°C)   36.8 (0.27 [36.4 - 37.2])  
Hb (g.dl-1)   12.3 (0.1 [11.0 - 13.5]) 
Hct (%)   38.0 (2.5 [34.1 - 41.3]) 
PCO2 (kPa)   5.54 (0.56 [4.87 - 6.7]) 
pH    7.33 (0.03 [7.22 - 7.40]) 
NaHCO3 (kPa)  21.3 (2.49 [17.80 - 26.7]) 
BE (kPa)   –3.94 (0.31 [8.5 - 1.0]) 
 
Abbreviations: Temp., temperature; Hb, haemoglobin; Hct, haematocrit; PCO2, partial 
carbon dioxide tension; NaHCO3; BE, base excess. 
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Table 2. Studies investigating the reliability of spectrophotometry-based continuous 
assessment of oxygen saturation  
 
• Author;ye
ar 
•  
• Wav
e 
• leng
th 
• No. of 
• subjec
ts 
• Pears
on 
•  
• Bi
as 
• (
%
) 
• Limits of 
• Agreeme
nt (%) 
•  •  •  •  •  •  
• Fahey; 
198414 
• 3 • 84 
patient
s 
• 0.95 •  •  
• Gettinger; 
198715 
• 3 
• 2 
• 10 
animal
s 
• 0.99 
• 0.81 
•  •  
• Zaune; 
199026 
• 2 
• 2 
• 15 
patient
s 
• 15 
patient
s 
• 0.87 
• 0.86 
• - 
1.3 
• - 
0.1 
• ± 2.8 
• ± 3.2 
• Pond; 
199225 
• 2 • 52 
patient
s 
• 0.92 • - 
1.7 
• ± 7.0 
• Scuderi; 
199421 
• 3 
• 2 
• 2 
• in 
vitro 
• in 
vitro 
• in 
vitro 
•  • + 
3.2 
• - 
1.3 
• - 
10.
0 
• ± 4.8 
• ± 6.6 
• ± 13.8 
• Armaganidis
; 199422 
• 3 
• 2 
• 1 
• 14 
patient
s 
• 15 
•  • + 
1.0 
• - 
0.2 
• ± 7.8 
• ± 8.1 
• ± 24.6 
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patient
s 
• 8 
patient
s 
• + 
1.3 
• Janvier; 
199420 
• 3 
• 2 
• 2 
• in 
vitro 
• in 
vitro 
• in 
vitro 
•  •  • ± 9.0 
• ± 8.6 
• ± 14.2  
• Rouby; 
199018 
• 3 
• 2 
• 2 
• 11 
patient
s 
• 8 
patient
s 
• 12 
patient
s 
• 0.97 
• 0.86 
• 0.83 
•  •  
• Bongard; 
199523 
• 3 
• 2 
• 7 
animal
s 
• 7 
animal
s 
• 0.99 
• 0.99 
• + 
3.7 
• + 
0.2 
• ± 2.3 
• ± 2.5 
• Kirkeby-
Garstad; 
200027 
• 2 • 61 
patient
s 
•  • - 
1.6 
• ± 11.4 
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Figure legends 
 
Fig 1 Experimental setting: position of the CeVOX fiberoptic probe in a light protection 
black box integrated into an exctracorporeal circuit. 
 
Fig 2  Linear regression plot for comparison of ScevoxO2 values and SO2 measured by co-
oximetry (n = 66; r2 = 0.97) (dotted line: line of identity). 
 
Fig 3  Bland-Altman plot for comparison of ScevoxO2 and SO2 measured by co-oximetry (n = 
66; mean bias +2.4%; limits of agreement [± 2 SD] –11.8 / +16.6%). Mean bias shows a 
nearly linear correlation with (ScevoxO2 + SO2 )/2 expressed in the equation (ScevoxO2–SO2) = 
15 – 0.19*SO2(%); R2 = 0.58 (dotted line) 
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Figures 
 
Figure 1. 
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Figure 2.  
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Figure 3. 
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